iSpecimen (ISPC) Capital Expenditures Growth (1y) (2021 - 2025)
iSpecimen (ISPC) Capital Expenditures Growth (1y) (2021 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 53.06% |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 8.47% |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 144.93% |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | -33.33% |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 31.13% |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | -27.73% |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 33.33% |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 16.40% |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 68.93% |
| 10 | iSpecimen | 2.25 Mn | -2.16 Mn | 68,650.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 611.90% |
| Dec 31, 2024 | -75.50% |
| Sep 30, 2024 | -81.76% |
| Jun 30, 2024 | -85.55% |
| Mar 31, 2024 | -82.11% |
| Dec 31, 2023 | -81.34% |
| Sep 30, 2023 | -0.31% |
| Jun 30, 2023 | 172.13% |
| Mar 31, 2023 | 353.93% |
| Dec 31, 2022 | 368.91% |
| Sep 30, 2022 | 165.47% |
| Jun 30, 2022 | 93.99% |
| Mar 31, 2022 | 58.09% |
| Dec 31, 2021 | 28.21% |
| Sep 30, 2021 | 6.18% |